Skip to content

Clinical trials

Major Depressive Disorder trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Brazil Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20104
20122
20133
20142
20152
20162
20172
20193
20202
20214
20226
20234
20244
20251
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status9
Recruiting8
Terminated6
Suspended2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo14
Janssen Research & Development, LLC12
Hospital de Clinicas de Porto Alegre4
Eli Lilly and Company3
University of Sao Paulo General Hospital3
Neumora Therapeutics, Inc.2
Universidade Federal do Rio Grande do Norte2
AstraZeneca1
Brain Institute of Rio Grande do Sul1
D'Or Institute for Research and Education1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder51
Depressive Disorder7
Mood Disorders5
Anhedonia4
Bipolar Disorder3
Depressive Disorder, Treatment-Resistant2
Recurrence2
Cognitive Dysfunction1
Headache Disorders1
Mental Disorders1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.